144 related articles for article (PubMed ID: 37837799)
1. Mechanism of molecular interaction of sitagliptin with human DPP
Gonzatti MB; Júnior JEM; Rocha AJ; de Oliveira JS; Evangelista AJJ; Fonseca FMP; Ceccatto VM; de Oliveira AC; da Cruz Freire JE
Adv Med Sci; 2023 Sep; 68(2):402-408. PubMed ID: 37837799
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
Musoev A; Numonov S; You Z; Gao H
Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
[TBL] [Abstract][Full Text] [Related]
3. More effective DPP4 inhibitors as antidiabetics based on sitagliptin applied QSAR and clinical methods.
Buiu C; Avram S; Duda-Seiman D; Milac AL; Duda-Seiman C; Pacureanu L; Borcan F
Curr Comput Aided Drug Des; 2014; 10(3):237-49. PubMed ID: 25756669
[TBL] [Abstract][Full Text] [Related]
4. Computer-Aided Screening of Phytoconstituents from
Sajal H; Patil SM; Raj R; Shbeer AM; Ageel M; Ramu R
Molecules; 2022 Aug; 27(16):. PubMed ID: 36014373
[TBL] [Abstract][Full Text] [Related]
5. Study on the Mechanism of Interaction between Dipeptidyl Peptidase 4 and Inhibitory Peptides Based on Gaussian Accelerated Molecular Dynamic Simulation.
Liu Y; Zhao W; Jiang Y; Xing S; Li W
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255913
[TBL] [Abstract][Full Text] [Related]
6. New Molecular Insights into the Inhibition of Dipeptidyl Peptidase-4 by Natural Cyclic Peptide Oxytocin.
Chittepu VCSR; Kalhotra P; Osorio-Gallardo T; Jiménez-Martínez C; Torre RRR; Gallardo-Velazquez T; Osorio-Revilla G
Molecules; 2019 Oct; 24(21):. PubMed ID: 31661941
[TBL] [Abstract][Full Text] [Related]
7. Effects of sitagliptin on blood pressure and heart rate in response to intraduodenal glucose infusion in patients with Type 2 diabetes: a potential role for glucose-dependent insulinotropic polypeptide?
Wu T; Trahair LG; Bound MJ; Deacon CF; Horowitz M; Rayner CK; Jones KL
Diabet Med; 2015 May; 32(5):595-600. PubMed ID: 25388434
[TBL] [Abstract][Full Text] [Related]
8. Microbial-host-isozyme analyses reveal microbial DPP4 as a potential antidiabetic target.
Wang K; Zhang Z; Hang J; Liu J; Guo F; Ding Y; Li M; Nie Q; Lin J; Zhuo Y; Sun L; Luo X; Zhong Q; Ye C; Yun C; Zhang Y; Wang J; Bao R; Pang Y; Wang G; Gonzalez FJ; Lei X; Qiao J; Jiang C
Science; 2023 Aug; 381(6657):eadd5787. PubMed ID: 37535747
[TBL] [Abstract][Full Text] [Related]
9. Head-to-head comparison of structurally unrelated dipeptidyl peptidase 4 inhibitors in the setting of renal ischemia reperfusion injury.
Reichetzeder C; von Websky K; Tsuprykov O; Mohagheghi Samarin A; Falke LG; Dwi Putra SE; Hasan AA; Antonenko V; Curato C; Rippmann J; Klein T; Hocher B
Br J Pharmacol; 2017 Jul; 174(14):2273-2286. PubMed ID: 28423178
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, nitric oxide release, and dipeptidyl peptidase-4 inhibition of sitagliptin derivatives as new multifunctional antidiabetic agents.
Xie Y; Shao L; Wang Q; Bai Y; Chen Z; Li N; Xu Y; Li Y; Yang G; Bian X
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3731-3735. PubMed ID: 30343953
[TBL] [Abstract][Full Text] [Related]
11. Citrus bioflavonoids dipeptidyl peptidase-4 inhibition compared with gliptin antidiabetic medications.
Gupta A; Jacobson GA; Burgess JR; Jelinek HF; Nichols DS; Narkowicz CK; Al-Aubaidy HA
Biochem Biophys Res Commun; 2018 Sep; 503(1):21-25. PubMed ID: 29698678
[TBL] [Abstract][Full Text] [Related]
12. Comparative Binding Analysis of Dipeptidyl Peptidase IV (DPP-4) with Antidiabetic Drugs - An Ab Initio Fragment Molecular Orbital Study.
Arulmozhiraja S; Matsuo N; Ishitsubo E; Okazaki S; Shimano H; Tokiwa H
PLoS One; 2016; 11(11):e0166275. PubMed ID: 27832184
[TBL] [Abstract][Full Text] [Related]
13. The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities.
Varela-Calviño R; Rodríguez-Quiroga M; Dias Carvalho P; Martins F; Serra-Roma A; Vázquez-Iglesias L; Páez de la Cadena M; Velho S; Cordero OJ
IUBMB Life; 2021 May; 73(5):761-773. PubMed ID: 33615655
[TBL] [Abstract][Full Text] [Related]
14. Glucose-lowering agents for treating pre-existing and new-onset diabetes in kidney transplant recipients.
Lo C; Jun M; Badve SV; Pilmore H; White SL; Hawley C; Cass A; Perkovic V; Zoungas S
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD009966. PubMed ID: 28238223
[TBL] [Abstract][Full Text] [Related]
15. DPP4 inhibition by sitagliptin attenuates LPS-induced lung injury in mice.
Kawasaki T; Chen W; Htwe YM; Tatsumi K; Dudek SM
Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L834-L845. PubMed ID: 30188745
[TBL] [Abstract][Full Text] [Related]
16. Changes in glucose-induced plasma active glucagon-like peptide-1 levels by co-administration of sodium-glucose cotransporter inhibitors with dipeptidyl peptidase-4 inhibitors in rodents.
Oguma T; Kuriyama C; Nakayama K; Matsushita Y; Hikida K; Tsuda-Tsukimoto M; Saito A; Arakawa K; Ueta K; Minami M; Shiotani M
J Pharmacol Sci; 2016 Dec; 132(4):255-261. PubMed ID: 27889414
[TBL] [Abstract][Full Text] [Related]
17. Modelling the sitagliptin effect on dipeptidyl peptidase-4 activity in adults with haematological malignancies after umbilical cord blood haematopoietic cell transplantation.
Vélez de Mendizábal N; Strother RM; Farag SS; Broxmeyer HE; Messina-Graham S; Chitnis SD; Bies RR
Clin Pharmacokinet; 2014 Mar; 53(3):247-259. PubMed ID: 24142388
[TBL] [Abstract][Full Text] [Related]
18. Exploring novel targets of sitagliptin for type 2 diabetes mellitus: Network pharmacology, molecular docking, molecular dynamics simulation, and SPR approaches.
Qi JH; Chen PY; Cai DY; Wang Y; Wei YL; He SP; Zhou W
Front Endocrinol (Lausanne); 2022; 13():1096655. PubMed ID: 36699034
[TBL] [Abstract][Full Text] [Related]
19. Ligand-based pharmacophore detection, screening of potential gliptins and docking studies to get effective antidiabetic agents.
Agrawal R; Jain P; Dikshit SN
Comb Chem High Throughput Screen; 2012 Dec; 15(10):849-76. PubMed ID: 23140189
[TBL] [Abstract][Full Text] [Related]
20. Dipeptidyl peptidase-4 inhibition prevents vascular dysfunction induced by β-adrenergic hyperactivity.
Oliveira BC; Marques VB; Brun BF; de Oliveira E Silva HM; Freitas Soares Melo S; Oliveira EM; Dos Santos L; Barauna VG
Biomed Pharmacother; 2019 May; 113():108733. PubMed ID: 30861410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
